Global Vaccine Trials Case Study

Two leading global pharmaceutical and biotechnology sponsors conducted global vaccine clinical trials from early 2022 to early 2024 across the US, Canada, Puerto Rico, France, Belgium, Germany, Spain, and the UK. The main challenge was to manage and support thousands of participants across these countries efficiently, each requiring rapid payment processing within a tight timeframe. This operation faced significant logistical and administrative challenges to ensure prompt and accurate compensation.

At the outset of their respective trials, the sponsors reached out to Scout with an extensive mandate: to provide comprehensive support that included multilingual 24/7 Patient Liaison assistance, develop technology for seamless financial transactions, and ensure international regulatory compliance, all while enhancing participant engagement and satisfaction from the very beginning.

Find out what happened next by downloading the case study below.